Company Filing History:
1 out of 1 
1 out of 78 
1 out of 950 
Years Active: 2012
Title: **Takeshi Okanoue: Innovator in Liver Disease Diagnostics**
Introduction
Takeshi Okanoue is a prominent inventor based in Kyoto, Japan, with a focus on medical diagnostics. He has contributed significantly to the field with a patented innovation that enhances the diagnosis of liver diseases, particularly non-alcoholic fatty liver disease (NAFLD). His work not only simplifies the diagnostic process but also provides critical insights into liver health.
Latest Patents
Okanoue holds a patent for a biomarker used in diagnosing liver diseases. This invention outlines a marker that allows for a straightforward determination of liver disease. The patent includes an antibody directed against the marker, diagnostic agents, a method of diagnosis, and techniques for marker detection in blood or serum. His proteome analysis revealed that the levels of full-length kininogen and specific peptides in the serum of patients with non-alcoholic fatty liver disease are significantly different from those in healthy individuals. Moreover, the combination of a kininogen-based marker and a C4-based marker facilitates the identification of conditions such as chronic hepatitis and asymptomatic virus carriers, highlighting Okanoue's valuable contributions to medical technology.
Career Highlights
Okanoue's career features notable collaborations with significant institutions like the Miyazaki Prefectural Industrial Support Foundation and Kagoshima University. His work in these organizations has undoubtedly bolstered his research and innovation capabilities, enabling him to make strides in medical diagnostics.
Collaborations
Throughout his career, Takeshi Okanoue has worked closely with esteemed colleagues, including Hirohito Tsubouchi and Hirofumi Uto. These collaborations have played a crucial role in the development of his groundbreaking diagnostic technologies.
Conclusion
In conclusion, Takeshi Okanoue stands out as a pioneering inventor in the realm of liver disease diagnostics. His innovative patent, which simplifies the diagnostic process for non-alcoholic fatty liver disease, demonstrates the potential for scientific advancements to improve healthcare outcomes. As he continues to pave the way for further innovations, Okanoue's contributions will undoubtedly leave a lasting impact on the medical community.